Back
Protalix BioTherapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
PLX
Protalix BioTherapeutics
Last Price:
1.64
Seasonality Move:
78.33%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Protalix BioTherapeutics Price Quote
$1.64
-0.05 (-2.96%)
(Updated: November 21, 2024 at 3:05 PM ET)
Protalix BioTherapeutics Key Stats
Buy
80
Protalix BioTherapeutics (PLX)
is a Buy
Day range:
$1.61 - $1.74
52-week range:
$0.82 - $1.90
Dividend yield:
0%
P/E ratio:
18.44
P/S ratio:
2.85
P/B ratio:
3.77%
Volume:
817.1K
Avg. volume:
345.1K
1-year change:
21.58%
Market cap:
$122.2M
Revenue:
$65.5M
EPS:
$-0.16
How Much Does Protalix BioTherapeutics Make?
-
How Much Are Protalix BioTherapeutics's Sales Annually?
PLX Revenues are $65.5M -
How Much Profit Does Protalix BioTherapeutics's Make A Year?
PLX net income is $8.3M
Is Protalix BioTherapeutics Growing As A Company?
-
What Is Protalix BioTherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.74% -
What Is Protalix BioTherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Protalix BioTherapeutics Stock Price Performance
-
Did Protalix BioTherapeutics Stock Go Up Last Month?
Protalix BioTherapeutics share price went up by 55.05% last month -
Did PLX's Share Price Rise Over The Last Year?
PLX share price rose by 21.58% over the past 1 year
What Is Protalix BioTherapeutics 52-Week High & Low?
-
What Is Protalix BioTherapeutics’s 52-Week High Share Price?
Protalix BioTherapeutics has traded as high as $1.90 over the past 52 weeks -
What Is Protalix BioTherapeutics’s 52-Week Low Share Price?
Protalix BioTherapeutics has traded as low as $0.82 over the past 52 weeks
Protalix BioTherapeutics Price To Free Cash Flow
-
Is Protalix BioTherapeutics Stock Overvalued?
Protalix BioTherapeutics is trading at a price to free cash flow ratio of 18.18 -
Is Protalix BioTherapeutics Stock Undervalued?
Protalix BioTherapeutics EV to Free Cash Flow ratio is 13.22 -
What Is Protalix BioTherapeutics’s Price Earnings Growth Ratio?
PLX PEG ratio is 0.00 -
Is Protalix BioTherapeutics Trading At A Premium To Earnings?
Protalix BioTherapeutics EV to EBIT ratio is 0.00
Is It Risky To Buy Protalix BioTherapeutics?
-
How Much Debt Does Protalix BioTherapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Protalix BioTherapeutics Have?
Cash and short term investments quarterly total is $27.4M -
What Is Protalix BioTherapeutics’s Book Value Per Share?
Book value per share is 0.44
Is Protalix BioTherapeutics Cash Flow Positive?
-
What Is PLX Cash Flow From Operations?
Cash flow from operations (TTM) is $8.3M -
What Is Protalix BioTherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$20.4M -
What Is Protalix BioTherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $19.2M
Protalix BioTherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PLX return on invested capital is -19.69% -
What Is Protalix BioTherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -11.58% -
What Is PLX Return On Equity?
ROE is a measure of profitability and is -29.54%
Protalix BioTherapeutics Earnings Date & Stock Price
-
What Is Protalix BioTherapeutics's Stock Price Today?
A single share of PLX can be purchased today for 1.69 -
What Is Protalix BioTherapeutics’s Stock Symbol?
Protalix BioTherapeutics trades on the nyam under the ticker symbol: PLX -
When Is Protalix BioTherapeutics’s Next Earnings Date?
The next quarterly earnings date for Protalix BioTherapeutics is scheduled on March 14, 2025 -
When Is PLX's next ex-dividend date?
Protalix BioTherapeutics's next ex-dividend date is May 26, 2020 -
How To Buy Protalix BioTherapeutics Stock?
You can buy Protalix BioTherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Protalix BioTherapeutics Competitors
-
Who Are Protalix BioTherapeutics's Competitors?
Below is a list of companies who compete with Protalix BioTherapeutics or are related in some way:
Protalix BioTherapeutics Dividend Yield
-
What Is PLX Dividend Yield?
Protalix BioTherapeutics’s dividend yield currently is 0% -
What Is Protalix BioTherapeutics’s Payout Ratio?
Protalix BioTherapeutics’s payout ratio is 0% -
When Did Protalix BioTherapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Protalix BioTherapeutics’s Dividend Per Share?
Protalix BioTherapeutics pays a dividend of $0.00 per share
Protalix BioTherapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 73.6% | 9.72% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 14.00 |
| Upside from Last Price: | 728.4% |